WKN: 548183 / ISIN: HK1093012172

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

CSPC Pharmaceutical Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
19:01:14	1,038
18:31:55	1,038
18:17:09	1,038
17:32:56	1,038
17:18:42	1,038
17:03:58	1,038
16:50:18	1,038
16:32:42	1,038
16:16:17	1,038
15:47:20	1,038
15:31:13	1,038
15:16:10	1,025
15:01:10	1,026
14:31:20	1,027
14:16:14	1,027
13:31:08	1,026
13:16:17	1,026
12:31:36	1,026
12:16:17	1,026
12:01:16	1,026
11:31:15	1,025
11:16:16	1,024
11:01:18	1,024
10:31:19	1,024
10:20:14	1,023
10:16:17	1,023
10:01:17	1,023
09:33:48	1,021
09:17:30	1,025
09:07:51	1,027
08:57:18	1,019
08:31:17	1,017
08:16:18	1,011
08:03:16	1,007
07:37:15	1,008

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu CSPC Pharmaceutical

Weitere Meldungen

18:59		Dick’s Sporting Goods’ epic drop hits other footwear giants, as shoppers sour on retro sneakers
18:42		Why Sandisk Stock Popped, Then Dropped Today
18:39		Western Digital vs. Seagate Technology: Which Data Storage Stock Is the Better Buy?
18:32		‘It’s the ultimate regifting’: My mom gave me a house. Should I transfer it back to her to reduce capital gains?
18:22		Alpha Metallurgical Resources Director Courtis Buys Again, This Time $3.2 Million in Shares. Is it Time for Investors to Buy Too?
18:20		If I Could Tell Every S&P 500 Investor Just 1 Thing About the Stock Market Right Now, It's This.
18:19		E.P.A. Moves to Curb Public Input on Air Pollution Permits for Data Centers
18:15		Should You Invest in the Vanguard Total World Stock ETF? Here's My Honest Take.
18:08		ROG Xbox Ally X20: OLED-Upgrade mit deutlichem Preisaufschlag
18:05		SpaceX Is Building a $16.8 Billion Chip Fab in Texas. Is This a Genius Move or a Red Flag For Investors?
18:04		These growth stocks are still cheap, despite the S&P 500 being near a record high price-to-sales valuation
18:02		Einhorn Vs. Musk: Hedge Fund Manager Says SpaceX IPO Was ‘Meme-ification of the Market’
18:00		Here’s How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
18:00		Here's Exactly What It Will Take for Madrigal Pharmaceuticals Stock to Take Off
17:57		Scott Bessent's Bond Plan 'Won't Work,' Citi Economist Says: US Fiscal Position Is 'Absolutely Out of Control'
17:57		EXCLUSIVE: Nvidia's Biggest Contribution to AI Drug Discovery Isn't Money, Generate CTO Says
17:57		Kura Oncology CEO Buys 100,000 Shares for $1.2 Million. Does This Large Buy Bode Well for Shares in 2026?
17:54		Why Marvell Technology Stock Is Rocketing Higher Today
17:53		Klarna (KLAR) Q2 2026 Earnings Call Transcript
17:53		Amer Sports (AS) Q2 2026 Earnings Call Transcript
17:53		Waymo kündigt Betrieb in München an
17:49		This Five Below Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
17:45		Salesforce Q2: AI Is Growing Fast, CRM Needs New Customers To Catch Up
17:45		Here’s How Much You Would Have Made Owning KLA Stock In The Last 10 Years
17:45		If I Could Tell All Investors 1 Thing About Buying at Record Highs, It Would Be This
17:44		What's Going On With Dell Technologies Stock Tuesday?
17:36		Nutanix Is Selling Plenty of Software. Growth May Cool as Hardware Stays Tight
17:31		Novavax Stock Rallies Tuesday: What's Happening?
17:31		McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization
17:31		Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today
17:30		Dell Technologies vs. UiPath: Which Technology Stock Is a Better Buy in 2026?
17:25		What's Going On With CoreWeave Stock Tuesday?
17:24		Browser-Tracking per Web Audio: Das verborgene Tonstudio
17:21		Palantir's Maven Is Now an Official Pentagon Program of Record. Here's What Guaranteed Budget Dollars Are Worth.
17:15		Here's How Much $1000 Invested In Ameriprise Financial 5 Years Ago Would Be Worth Today
17:15		Netflix Stock Is Down Big-Time. Is This Finally a Buying Opportunity?
17:14		Synopsys Q3 Preview: 40% Revenue Growth On AI Products, Ansys Acquisition
17:11		Accenture Buys McCoy To Accelerate Midmarket AI Expansion
17:08		Shipbuilder Penguin International wins first prime contract with Singapore Navy
17:07		Dick's Sporting Goods Stock Plunges 25% on $31.9M Foot Locker Investment Loss
17:04		Intuit Stock Falls Ahead of Q4 Earnings: What Investors Need to Know
17:04		What Nvidia says on Wednesday to address concerns about its competitiveness could be key for the stock
17:03		Nebius Group N.V. vs. SoundHound AI: Which AI Stock Will Bring You Profits in 2026 and Beyond?
17:02		Trump’s Canada Tariffs Rely on Untested Law
17:02		Humanoid Robots Could Match Humans Within 5 Years, RoboStrategy CEO Says
17:00		DICK'S Faces Painful Sneaker Reset As Legacy Styles Lose Favor
16:46		Cisco Expands Rack-Scale AI Computing With Nvidia, Supermicro
16:45		Here's How Much $100 Invested In Johnson Controls Intl 15 Years Ago Would Be Worth Today
16:45		Billionaire Bill Ackman Has 10.5% of His $19.5 Billion Portfolio in Amazon. What's the Thesis Behind Pershing Square's Bet?
16:41		Kalshi's Nvidia Compute Markets Hit $4.4M: Is AI Compute the 'New Oil'?

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: F&C Investment Trust M.D.C. Holdings Psychiatric Solutions The Cheesecake Factory GW Pharmaceuticals

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	25.08.2026 19:15
Kaufwert:	EUR
	Hinzufügen Speichern

CSPC Pharmaceutical Aktie

WKN: 548183 / ISIN: HK1093012172

CSPC Pharmaceutical Times and Sales (STU)

Analysen zu CSPC Pharmaceutical

Weitere Meldungen